Booster shingles vaccine for adults 50 and older
Part of Immune system & allergy, Infections clinical trials.
This study tests a live, weakened shingles vaccine given as a booster after a different type of shingles vaccine. It may help strengthen your protection against shingles.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years of age or older.
- You have never had shingles (herpes zoster) before.
- You have not received any shingles or chickenpox vaccine in the past.
- You do not have a weakened immune system (from conditions like cancer, HIV, or treatments that lower immunity).
- You are not allergic to any component of the study vaccine.
- If you are a woman who can still have children, you are not pregnant and will not become pregnant for 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new shingles vaccine in adults 40 and older to see if it is safe and works well. The vaccine is designed to prevent shingles and its complications, which are common in this age group.
This study tests a new vaccine to protect against shingles (herpes zoster), a painful skin infection that can affect people as they age. You would receive the vaccine and be monitored to see if it's safe and how your body responds.
This study tests a new vaccine to prevent shingles (a painful rash condition) in adults 50 and older. It checks how safe the vaccine is and how well it triggers the body's immune defense.
This trial tests a new shingles vaccine for healthy adults 40 and older. It aims to see if the vaccine is safe and helps protect against shingles.
This trial tests a new shingles vaccine to see how well it prevents shingles in adults aged 40 and older. It aims to help those who have not had shingles recently or been vaccinated against it before.
This trial tests an experimental vaccine designed to prevent shingles (a painful rash caused by the varicella-zoster virus). It will help see if the vaccine is safe and triggers a good immune response in adults 40 and older.
Hear when a new Herpse Zoster trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.